HEMISULFATE OF 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID
To provide a hemisulfate of 5,10-methylene-(6R)-tetrahydrofolic acid in a substantially crystalline form, pharmaceutical compositions, and methods of using the same in therapy, preferably chemotherapy.SOLUTION: The invention provides a hemisulfate of 5,10-methylene-(6R)-tetrahydrofolic acid. Prefera...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English Japanese |
Published |
08.08.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To provide a hemisulfate of 5,10-methylene-(6R)-tetrahydrofolic acid in a substantially crystalline form, pharmaceutical compositions, and methods of using the same in therapy, preferably chemotherapy.SOLUTION: The invention provides a hemisulfate of 5,10-methylene-(6R)-tetrahydrofolic acid. Preferably, the hemisulfate is in a substantially crystalline form, and has a crystalline purity of at least 80%, preferably 90%, preferably 95%, more preferably 97%, most preferably 99% or more.SELECTED DRAWING: None
【課題】実質的に結晶質形態にある、5,10−メチレン−(6R)−テトラヒドロ葉酸のヘミ硫酸塩、並びに、医薬組成物およびその治療、好ましくは化学療法における使用法の提供。【解決手段】5,10−メチレン−(6R)−テトラヒドロ葉酸のヘミ硫酸塩であり、好ましくは、実質的に結晶質形態にあり、少なくとも80%、好ましくは90%、好ましくは95%、より好ましくは97%、最も好ましくは99%またはそれ以上の結晶純度を有する、該ヘミ硫酸塩。【選択図】なし |
---|---|
Bibliography: | Application Number: JP20190070293 |